Pharma executives flouted compliance rules when striking supply agreement, CMA claims

An in-house lawyer at a drugmaker since bought out by Advanz Pharma allowed the company’s most senior staff to hold meetings without strictly abiding by certain compliance rules, counsel to the UK's Competition and Markets Authority has claimed.

Unlock unlimited access to all Global Competition Review content